Dr. Hemalatha Ramachandran

@K_Yadavir @MedTwX @LungSummit @ASCOPost @thoracic @nlinmd @DrHBurstein @NiuSanford A useful reminder that treatment strategy matters more than agent selection in this setting. The consistent survival benefit with chemo-immunotherapy supports its role as standard of care in ES-SCLC, while ongoing research may further refine patient selection. #SCLC #Oncology

Does it matter: PD-1 vs PD-L1 in ES-SCLC? 👉 Meta-analysis says NO significant difference 👉 But clear OS benefit with chemo-immunotherapy Practice-changing evidence 👇 #Oncology #LungCancer @MedTwX @LungSummit @ASCOPost @thoracic @nlinmd @DrHBurstein @NiuSanford @DraMartinezLago @Sciencedirect @csoncol @oncodaily

@DrSamuelBHume An exciting and rapidly evolving area, with mRNA platforms showing promise in personalised cancer vaccines and improved antitumour immunity. Ongoing phase 3 trials in lung cancer and melanoma will be pivotal in defining their clinical role. #CancerResearch #mRNA #Oncology

RNA vaccines could revolutionise cancer therapy These are the clinical trials that are ongoing, including phase 3 trials for lung cancer and melanoma (cell.com/cancer-cell/fu…)

@kevinmd A powerful reminder of how transformative early detection can be. Outcomes like yours highlight the value of timely diagnosis and personalised treatment, especially in populations not traditionally considered high risk. #LungCancer #EarlyDetection #Survivorship

Early lung cancer detection saved my life. Catching lung cancer early can be a game-changer. I was incredibly fortunate to have mine detected at stage one, with no lymph node involvement. No chemotherapy needed, just a curative right upper lobe resection. I've been on targeted therapy for almost three years now, and I'll be wrapping that up this summer. Early screening for non-smokers is crucial—imagine the lives we could save. Have you or someone you know experienced early detection making a difference? Alice S. Y. Lee is an emergency physician. SUBSCRIBE TO THE PODCAST → kevinmd.com/podcast #LungCancerAwareness #EarlyDetection #NonSmokers #LungCancerSurvivor #TargetedTherapy #HealthScreening #CancerResearch #MedicalAdvancements #PatientAdvocacy

@JAMA_current An important focus, as lung cancer in never-smokers is increasingly recognised with distinct risk factors, biology, and treatment considerations. #LungCancer #Oncology #PublicHealth

Lung cancer is the leading cause of cancer-related mortality worldwide, causing approximately 1.8 million deaths in 2022. 📝 This Review discusses the epidemiology, diagnosis, treatment, and prognosis of lung cancer in nonsmoking individuals. ja.ma/48LzQv2

@diegoadiazg An important and concise summary highlighting the aggressive biology and late presentation of SCLC. Despite advances with chemo-immunotherapy, relapse rates remain high, underscoring the need for better therapeutic strategies and early detection. #SCLC #LungCancer #Oncology

🫁 Small Cell Lung Cancer. SCLC remains a highly aggressive smoking-related malignancy. • 70% present with extensive-stage disease • 5-year OS: 12% • Brain metastases at diagnosis: ~15-20% Treatment: LS-SCLC → concurrent chemoradiation ± durvalumab. ES-SCLC → platinum–etoposide + PD-L1 inhibitor ± lurbi maintenance. Relapse remains common. 📖 @JAMA_current DOI 👉🏻 10.1001/jama.2025.0560 #CánCare #SCLC #lcsm #ThoracicOncology #Immunotherapy

@EricTopol Rising Lung Cancer in never-smokers highlights major gaps in prevention, early detection, and environmental risk control. We need urgent focus on air quality, screening strategies, and public health action. #LungCancer #PublicHealth #AirPollution #Prevention #EarlyDetection

Lung cancer in people who never smoked is on the rise. But little to nothing is being done to prevent it, detect it early, or address known environmental risk exposures cell.com/trends/cancer/…

@LungCancerEu Severe COVID-19 may increase later Lung Cancer risk by altering the lung environment and accelerating tumour growth. Findings from large-scale data and models highlight the long-term impact of severe respiratory infections. #COVID19 #LungCancer #Oncology #PublicHealth #Research

‼️Severe COVID-19 may be associated with an increased subsequent risk of #lungcancer. A new study in Cancer Cell suggests prior severe respiratory viral infection can leave lasting changes in the lung environment that may accelerate tumour growth. Evidence comes from analysis of a 75.9 million adult cohort alongside experimental models. 🔗 cell.com/cell/abstract/… #LCSM

@DrSamuelBHume GLP-1 therapies show promise beyond diabetes targeting alcohol use, smoking, and even stroke recovery. From epigenetic editing in cholesterol to AI transforming cardiology, medicine is entering a powerful new era. #GLP1 #AIinHealthcare #Cardiology #PrecisionMedicine

GLP1s for alcohol overuse/smoking, a novel mechanism that drives lung cancer, a new possibility to help stroke patients, the prospect of epigenetic editing for high cholesterol, and AI helping cardiologists All in a week - exciting stuff:

@DrKristieLeong Absolutely! Lung Cancer in non-smokers is a growing concern, and air pollution is a major driver we can’t ignore. Cleaner energy and stronger emission policies are essential because every breath truly matters. #LungCancer #AirPollution #CleanAir #PublicHealth #Prevention

Lung cancer doesn’t just affect smokers. New data shows that the disease is increasingly impacting non-smokers, largely due to rising air pollution levels. As clean energy solutions emerge, we must advocate for stricter emissions policies to reduce cancer risk. Every breath counts! 🌱🚗 #CleanAirForAll #PreventCancer

@HeartlandCntr Protecting lung health at work is crucial, especially with long term concerns like Lung Cancer. #LungHealth #LungCancer #CancerAwareness

Key points - The pneumoconiosis is a group of lung diseases caused by the lung’s reaction when breathing in certain dusts. - The main cause of the pneumoconiosis is workplace exposure. - All forms of pneumoconiosis can be severe.

@TheProspect A serious reminder of the impact of Silicosis among workers exposed to engineered stone. Strengthening prevention and awareness is key to protecting long term lung health, including risks like Lung Cancer. #LungCancer #LungHealth #CancerAwareness

Silicosis is a public health crisis among stone fabrication workers cutting engineered stone, killing 29 people in California alone. Doctors and public health officials believe stricter industry regulations are not enough to stop the growing epidemic. buff.ly/kdhKHhP

@WCRF_CA A critical reminder of the disparities in outcomes for Endometrial Cancer. Addressing awareness, access, and early detection is essential to help close this gap. #EndometrialCancer #WomensHealth #GynecologicCancer

Research indicates Black women are more likely to be diagnosed with more aggressive #endometrial #cancer, to be diagnosed at a later stage, and to die from the disease. This gap is one of the largest racial disparities observed in any type of cancer. everydayhealth.com/cancer/what-bl…

@CACancerJournal @kgunturuMD @HinaKhanMD @GlopesMd @OncoAlert Insightful discussion on evolving strategies in Non-Small Cell Lung Cancer. Early treatment intensification could play an important role in improving outcomes. #LungCancer #LungHealth #CancerAwareness

Editorial by @kgunturuMD @HinaKhanMD @GlopesMd on targeting tumor suppressor gene co‐mutations in EGFR-mutant nonsmall cell lung cancer. Authors discuss how the ACROSS2 phase 3 trial sharpens the case for early intensification. Read here: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @OncoAlert

@biohackyourself Interesting potential for simple biomarkers like MMP-7 and TNF-α in conditions such as Pulmonary Langerhans Cell Histiocytosis. Advances in early prediction could also support better monitoring of broader risks like Lung Cancer #LungHealth #LungCancer #CancerAwareness

Simple Blood Test May Help Predict Lung Disease Outcomes in Adults. Blood MMP-7 and TNF-α levels as potential prognostic biomarkers for adult pulmonary Langerhans cell histiocytosis. Could this be a game-changer in managing lung diseases? Check out the commentary and perspective on this groundbreaking research at the link in bio. Source: nature.com/articles/s4159… Published Date: February 18, 2026 👉 Comment BIOHACK if you want more science and health news like this! #BiohackYourself #HealthNews #ScienceNews #ResearchUpdates #Biohack Disclaimer: This content is for educational and entertainment purposes only and is not a substitute for medical advice. Always consult a healthcare professional. Full disclaimer: biohackyourself.com/termsanddiscla… 🧠 We explore all angles — ancient wisdom, modern science, and everything in between. No allegiance to Big Pharma or Big Natural. 🔍 We cite studies, but encourage you to read them, question funding, and review the methods. Stay curious. 📚 Not all journals are equal. Peer-reviewed ≠ perfect. Check the source, think critically, and decide for yourself. ⚠️ One study isn’t the full story. Science evolves. We’re here to inform, not to tell you what to believe.

@kgusler Promising early progress for Endometrial Cancer. Advances like this in immunotherapy could help expand future treatment possibilities. #EndometrialCancer #WomensHealth #GynecologicCancer

Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests: medicalxpress.com/news/2026-03-u…

@CancerAlliance Asbestosis and Mesothelioma may share the same exposure, but they differ in important ways. Understanding these distinctions also supports awareness of broader risks like Lung Cancer. #LungHealth #LungCancerAwareness

Asbestosis and mesothelioma are both linked to asbestos exposure, but are not the same condition. They can share some symptoms, but affect the body differently. Learn how symptoms, diagnosis and prognosis compare – and why the differences matter.buff.ly/THdGPXg

@AMJ_Reviews Interesting findings on potential benefits of ACE inhibitors in Idiopathic Pulmonary Fibrosis. Managing chronic lung conditions well may also support overall lung health and vigilance for risks like Lung Cancer. #LungHealth #LungCancerAwareness

Could a common heart medication improve survival rates in idiopathic pulmonary fibrosis? New evidence suggests that ACE inhibitors, typically used for blood pressure, are associated with lower mortality in patients with IPF. View more: hubs.la/Q0425LXf0

@HealioPulm @LancetDigitalH Important insight into improving cough assessment. Better monitoring could support earlier detection of underlying conditions, including concerns like Lung Cancer. #LungHealth #LungCancer #CancerAwareness

When monitoring #cough, both subjective and objective measures are needed, but use of objective cough counting tools is lacking in clinical practice, according to a review in @LancetDigitalH. 💬Healio spoke with Alexandra J. Zimmer, PhD, to learn more. vist.ly/4u2gc

@JAMA_current Helpful overview of Interstitial Lung Disease and its impact. Long term lung conditions also highlight the importance of monitoring for related risks like Lung Cancer. #LungHealth #LungCancer #CancerAwareness

Interstitial #LungDisease (ILD) is characterized by inflammation and/or fibrosis within the alveolar interstitium of the lung, affecting approximately 650 000 people in the US. This Review summarizes the diagnosis and treatment of ILD. 📑 Cite now: ja.ma/4rtQVR9

@NutrioSci Promising research showing how targeted metabolic approaches may enhance cancer treatment responses. Studies like this could help improve outcomes for certain lung cancer subtypes in the future. #LungCancerResearch #Immunotherapy

High-dose ascorbic acid selectively induces pyroptosis in LKB1-deficient lung cancer and sensitizes immunotherapy Open Access sciencedirect.com/science/articl…